As trade tensions show signs of easing, European markets have experienced a positive upswing, with the STOXX Europe 600 Index rising by 2.77%, reflecting optimism in the region's economic resilience despite global uncertainties. In such an environment, high growth tech stocks in Europe can be particularly appealing as they often thrive on innovation and adaptability, qualities that are essential for navigating fluctuating market conditions.
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Archos | 21.07% | 36.58% | ★★★★★★ |
Pharma Mar | 25.21% | 43.09% | ★★★★★★ |
Bonesupport Holding | 28.91% | 53.88% | ★★★★★★ |
Elicera Therapeutics | 63.53% | 97.24% | ★★★★★★ |
Ascelia Pharma | 43.57% | 70.39% | ★★★★★★ |
CD Projekt | 33.78% | 37.39% | ★★★★★★ |
Yubico | 20.08% | 25.52% | ★★★★★★ |
XTPL | 97.45% | 117.95% | ★★★★★★ |
Elliptic Laboratories | 49.76% | 88.21% | ★★★★★★ |
Xbrane Biopharma | 33.71% | 82.67% | ★★★★★★ |
Click here to see the full list of 222 stocks from our European High Growth Tech and AI Stocks screener.
We'll examine a selection from our screener results.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Izertis, S.A. is a company that offers technological consultancy services across Spain, Portugal, and Mexico with a market cap of €249.58 million.
Operations: Izertis generates revenue primarily from its Technologies and Information (IT) segment, which amounts to €124.33 million.
Izertis stands out in the European tech landscape with its robust growth metrics, evidenced by a projected annual revenue increase of 24.4% and earnings growth of 37.7%. These figures notably surpass the broader Spanish market's growth rates of 5.1% for revenue and 5.5% for earnings, highlighting Izertis's exceptional performance within its sector. Despite challenges in covering interest payments from earnings, the company continues to innovate and expand its market presence, promising a dynamic future trajectory in the evolving tech industry.
Understand izertis' track record by examining our Past report.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Lumibird SA is a company that specializes in the design, manufacture, and sale of lasers for scientific, industrial, and medical applications globally with a market capitalization of approximately €220.09 million.
Operations: Focusing on two main revenue segments, Lumibird SA generates €107.75 million from its Medical division and €99.37 million from its Photonic division. The company is involved in the global laser market, serving scientific, industrial, and medical sectors with a diverse product range.
Lumibird, a player in the European tech scene, demonstrates robust potential with its earnings forecast to surge by 48.7% annually, significantly outpacing the French market's growth of 12.1%. Despite a challenging past year with a one-off loss of €3.4M affecting its financials, the company's revenue growth remains promising at 7% per year, above the national average of 5.3%. This growth is supported by strategic initiatives and innovations that could reshape its market standing amidst stiff competition in the tech industry.
Examine Lumibird's past performance report to understand how it has performed in the past.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Fortnox AB (publ) offers innovative technical solutions for financial and administrative applications tailored to small and medium-sized businesses, accounting firms, and organizations in Sweden, with a market cap of SEK52.80 billion.
Operations: The company delivers a range of smart technical products and services designed for financial and administrative needs, focusing on small to medium-sized enterprises, accounting firms, and organizations within Sweden.
Fortnox's recent performance underscores its robust position in the European tech landscape, with first-quarter sales soaring to SEK 563 million from SEK 467 million year-over-year. This growth is complemented by a substantial net income increase to SEK 210 million, up from SEK 149 million, reflecting a solid earnings per share growth from SEK 0.24 to SEK 0.34. Amidst this financial upturn, Fortnox is also at the center of a significant acquisition proposal by First Kraft Ab and EQT AB, valuing the company at approximately SEK 54.9 billion—a testament to its strategic value and market confidence. This move could reshape Fortnox’s future trajectory in high-growth sectors within tech, enhancing its innovative capabilities and market reach.
Learn about Fortnox's historical performance.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BME:IZER ENXTPA:LBIRD and OM:FNOX.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.